Cd36 mRNA levels are drastically increased in livers of murine models of obesity and T2D (7), and CD36 expression correlates with liver TG accumulation, insulin resistance, and hyperinsulinemia in human NAFLD (8, 9). The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.